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ABSTRACT  
 
Objective  
To determine women’s (patients’) experiences of intrauterine device (IUD) insertion under 
our current practice and the extent to which these agreed with the observations of the health 
professionals (providers) who had performed the IUD insertion procedures. 
 
Method  
Questionnaires were used to collect information on women’s experiences of the IUD 
insertion procedure from both patients and providers in a sexual and reproductive health 
service. 
 
Results 
Overall response rates were high (77%, 284 responses in total). Seventy-three percent of 
patients were nulliparous and over half nulligravid. The providers predominantly used local 
anaesthesia for IUD insertions (93%). Most patients reported being anxious before their 
procedure (86%). Patients mainly described the overall experience of their IUD insertion 
procedure as being associated with ‘minimal discomfort/nothing’ (42%) or ‘uncomfortable’ 
(41%). ‘Minimal discomfort/nothing’ (56%) and ‘uncomfortable’ (33%) were the main 
observations of providers. When responses of patients and their providers were compared, 
agreement was slight for reported pain levels (k = 0.167 CI [0.13 – 0.24]). Patients’ reported 
pain levels were significantly higher than those reported to have been observed by their 
providers (P < 0.001). 
 
Conclusion 
Patients’ and providers’ responses suggested that the IUD insertion procedure under our 
current practice appeared acceptable to most patients. However, providers were not usually 
accurate in their observations and tended to underestimate the degree of pain experienced by 
their patients during IUD insertion procedures. 
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INTRODUCTION 
 
Contraception is provided free of charge to women in the UK under the National Health 
Service (NHS). However, up to a third of pregnancies in the UK are unplanned and abortion 
rates are high at over 185,000 per year
1
. Expert opinion suggests that increased use of long-
acting reversible contraception (LARC) could lower unintended pregnancy rates
2
. 
Intrauterine contraception is one such LARC, but its uptake in the UK is still low
3
 despite 
being the most commonly used LARC worldwide
4
 and associated with high continuation 
rates
5–7
.  
 
Current recommendations are that women wishing to use intrauterine contraception should be 
given information, counselled and offered available pain relief for the insertion procedure.
8,9
 
More information on the experiences of women undergoing intrauterine device insertions 
(patients) and observations of health professionals (providers) regarding the degree of pain or 
discomfort women experience will be useful. Exploring patients’ experiences and providers’ 
observations under current practice will facilitate further understanding of women’s 
experiences, provide information for prospective intrauterine contraception users and 
potentially stimulate more research. Such information may also guide providers who contend 
that they can accurately predict women’s sensitivity to pain and requirement of pain relief for 
intrauterine device (IUD) insertion procedures. 
 
We carried out a study to determine the pain or discomfort, if any, experienced by women 
having an IUD (either a T-shaped copper or levonorgestrel impregnated intrauterine device) 
inserted under our current practice and the extent to which this agreed with estimates of the 
women’s pain or discomfort by the health professionals inserting the device. We also 
examined whether any pain or discomfort experienced was related to or influenced by the 
age, gravidity, or parity of the woman. 
 
METHODS 
 
A survey was performed of both patients and providers to measure the extent of anxiety 
before and degree of pain during IUD insertion as recalled by the women and as perceived by 
their health professionals respectively. Women aged 16 or older, literate in English and 
seeking intrauterine contraception and who gave consent to complete a questionnaire 
concerning their experience at insertion, were eligible.  
 
Because no standardised questionnaires are available for determining pain or discomfort with 
IUD, specific questionnaires were developed for this study which were validated and pre-
tested before commencement of the study. These questionnaires were designed for (1) health 
professionals who had inserted IUDs at our health service during the study period, and (2) 
those women who had IUD insertions at our service during the study period. Questionnaires, 
designated as 1 and 2, were printed on papers of different colours for easy identification. 
Each questionnaire was numbered so as to enable them to be paired subsequently after 
completion. Both health professionals and women were asked to rate the woman’s anxiety 
before the procedure with the following scores: 1 representing very anxious, 2 a little anxious 
and 3 not anxious at all. A woman’s overall experience of the IUD insertion procedure was 
scaled from 1 to 3 with 1 representing painful, 2 uncomfortable and 3 minimal or no 
discomfort or nothing. How painful a woman found the procedure was scored on a numerical 
rating scale of 0 to 10, where 0 represented no pain at all and ranged up to 10, the worst pain 
imaginable. Additionally, health professionals documented the use of local anaesthesia while 
women provided demographic details and obstetric history. No participant identifiable data 
was recorded or collected on any of the questionnaires. The setting for this study was a 
London sexual and reproductive health (SRH) service which performed about a hundred IUD 
insertions per month and had an established practice of routinely offering patients local 
anaesthesia for IUD insertions. Local anaesthesia available in this service consisted of 2% 
Lidocaine gel (11 ml, Instillagel
®
) used topically and/or 3% Plain Mepivacaine (2.2 ml, 
Scandonest
®
) by intracervical injection. Ethical approval for this study was granted following 
review by the County Durham and Tees Valley Research Ethics Committee, UK. Local NHS 
Research and Development approval was obtained from the North Central London Research 
Consortium. Cardiff University acted as sponsor for this study. Health professionals who 
performed IUD insertions at the service were informed about the study by email and at a staff 
meeting prior to the study start date. The SRH service staff placed attached copies of 
Questionnaire 1 and 2 and their respective information sheets in the patient folders of each 
woman who attended for IUD insertion. Upon completion of the insertion procedure and 
consultation, the health professional informed each woman of the survey, detached 
Questionnaire 2 with its information sheet and handed to it to her. The women were assured 
that the completed questionnaire could not be identified with any individual. Women 
interested in the study read the participant information sheet and completed Questionnaire 2 
in a waiting area outside the consultation room. Health professionals willing to participate in 
the study completed Questionnaire 1 while still in the consultation room but after the woman 
had left. Persons who declined participation were not required to return the questionnaire, or 
could return it blank. Questionnaires were returned to a labelled box in the patient waiting 
area. 
 
DATA ANALYSIS 
 
All women who responded were included in the pertinent analyses. The variables collected 
from patients were age, previous pregnancy and previous vaginal delivery. The outcome 
variables were anxiety, overall experience and pain scores obtained from both patients and 
providers. Anxiety and overall experience were rated using an ordinal scale. Pain level was 
rated using an 11-point (0 to 10) numerical rating scale (NRS). Reported pain scores were 
further grouped into categories of mild (0 – 3), moderate (4 – 6) and severe pain (7 – 10) for 
easier communication of the results. To compare reported pain scores of patients and 
providers overall and by women’s age, gravidity and parity, and to compare patients’ and 
providers’ reported anxiety levels before insertion and overall experience of the IUD 
insertion procedure, the Wilcoxon test for  matched-pairs was applied. In order to probe the 
relationship between each age group, previous pregnancy and previous vaginal delivery; and 
each patient’s pain score and their provider’s perceived pain score, Kruskal-Wallis equality-
of-populations rank test or Mann-Whitney test was employed as appropriate. 
 
To evaluate agreement between patients’ and providers’ reported anxiety before insertion, 
overall experience of the IUD insertion procedure and pain scores, chi-squared kappa 
statistics were used. A kappa coefficient is a statistical measure of agreement between two 
independent observers. A kappa of 1 indicates total agreement, a kappa of 0 indicates 
agreement equivalent to that obtainable purely by chance while a kappa of - 1 indicates total 
disagreement. Kappa values ranging from 0.01 – 0.20 and 0.21 – 0.40 were considered as 
slight agreement’ or ‘fair agreement’ respectively10. All analyses were performed using 
StataSE 12, with a significance level of ≤5%. 
 
 
RESULTS 
 
A total of 284 questionnaires were returned. Partially completed questionnaires were included 
for the questions that had been answered. Seven paired responses (14 questionnaires) were 
excluded because they were found to be still attached (if the woman questionnaire was not 
separated from the health professional questionnaire, then they may not have been completed 
confidentially). This gave a response rate of 77% respectively in both women (n =135) and 
health professionals (n = 135). Each questionnaire from a woman (patient) was subsequently 
paired with its counterpart health professional (provider) questionnaire where available. For 
comparisons of responses obtained from patients and their providers, 129 paired responses 
were obtained for anxiety and overall experience respectively and 126 for reported pain 
scores. Women in the 25 – 34 age group formed the majority (54%), with no participants in 
the age range 16 – 19; 73% had never had a vaginal delivery and 54% had never been 
pregnant (Table 1). The preponderance of women reported feeling a little anxious before their 
IUD insertion procedure (65%). A total of 41% described their insertion as being associated 
with ‘minimal discomfort/nothing’. The same percentage, 41 (but with one less woman), 
described the insertion as ‘uncomfortable’. Health professionals considered that most (56%) 
of the women felt a little anxious before the procedure and perceived ‘minimal 
discomfort/nothing’ during the insertion. The providers also reported that 33% of the women 
had been ‘uncomfortable’ during the insertion. Reported pain score distribution of patients 
and their providers was not similar (Figure 1). Most pain scores reported by patients were 
higher (median [interquartile range, IQR]: 4 [2 – 6]) than the pain scores reported by their 
providers (3 [2 – 4]), and irrespective of whether the woman had been previously pregnant or 
had had a vaginal delivery in the past. The differences in patients’ and providers’ reported 
pain scores were found to be statistically significant (p <0.001; Table 2). 
 
When pain score responses were grouped into categories of mild (0 – 3), moderate (4 – 6) and 
severe pain (7 – 10), 43% (n = 58) of women reported experiencing mild pain, 40% (n = 54) 
moderate pain and the remainder severe pain (17%, n = 22). These ratios were similar to the 
descriptions of their overall experience of the IUD insertion procedure. Patients’ descriptions 
of their overall experience of the IUD insertion procedure were significantly different when 
the comparison was based on previous pregnancy (p<0.002) and previous vaginal delivery (p 
= 0.007), but they were not found to be related to their reported anxiety level before the 
procedure (p = 0.601). Providers’ perception of women’s overall experiences on the other 
hand was only significantly different when the comparison was based on previous vaginal 
delivery (p < 0.01). 
 
Patients’ anxiety, overall experiences and pain scores were further compared with those as 
perceived by their providers for agreement. There was slight to fair agreement on anxiety 
levels (k = 0.194 [0.06 – 0.35]) and reported pain scores (k = 0.167 [0.13 – 0.24]) and fair to 
slight agreement (k = 0.251 [0.13 – 0.37]) on overall experiences of the IUD insertion 
procedure (Table 3). 
 
Local anaesthesia was used for 93% of the IUD insertions with the majority (80%) of patient 
participants having received injectable local anaesthestic alone and very few (3%) having had 
both topical gel and injectable local anaesthetic administered. In the case of those patients 
who received topical gel alone (10%) the mean topical gel contact time before insertion was 2 
minutes. The pain experienced by the 10 patients (7%) who did not have local anaesthesia 
with their IUD insertion was reported by these patients as mainly minimal or nothing (n = 5), 
with their pain scores ranging from 0 to 8. Most of these women had been pregnant before (n 
= 8) and half of them had had a previous vaginal delivery (n = 5). 
 
 
DISCUSSION 
 
Findings and interpretation 
 
This study indicated that where local anaesthesia was used routinely, most women reported 
mild pain with IUD insertion, and described the procedure overall as being associated with 
minimal or no discomfort. Women who experienced moderate pain according to their pain 
scores, mainly described their procedure as being ‘uncomfortable’, rather than ‘painful’. This 
suggested that the IUD insertion procedure was tolerated by the majority of these women 
irrespective of age, gravidity or parity. Health professionals’ perceptions were similar to the 
women’s reports of pain, though there was disparity in their assessments in approximately 
half of the cases. This suggests that although the providers were sensitive to the patients’ 
experience during the procedure, they were not consistently accurate in their assessment of 
the severity of patients’ pain. 
 
Strengths and weaknesses 
 
The present investigation had the following strengths. Pain score responses were grouped into 
the categories of mild (0 – 3), moderate (4 – 6) or severe (7 – 10) pain. These are readily 
understandable labels of pain severity used in clinical settings. It was also for the reason of 
clarity that words like ‘painful’ and ‘uncomfortable’ were options to describe any pain 
experienced, since these terms are also commonly used by patients and providers in the study 
setting. An 11-point (0 – 10) numerical rating scale (NRS) was used in the questionnaires 
administered after the IUD insertion procedure rather than employing a visual analogue scale 
(VAS) administered upon IUD placement. This was to ensure minimal interference with the 
consultation routine as well as maximising the objectivity and confidentiality of patients’ 
responses since provider explanation of a VAS might introduce bias. Previous comparisons 
have found fewer practical difficulties with NRS than VAS, and NRS has proved just as 
sensitive as VAS in assessing pain in gynaecology.
11 – 14
 
The present investigation took place in an SRH service with women and health professionals 
who consented to take part. While systematic differences between those who consented to 
take part and those who did not cannot be ruled out, the response rate was relatively high 
which favours the generalisability of its findings for similar populations. A potential study 
weakness is asking questions about anxiety experienced before the IUD insertion 
immediately after the procedure, as this introduces the possibility of recall bias. Although the 
relevant time period was short (typically ten minutes or less between IUD placement and 
completion of the questionnaire), the overall insertion experience could have affected 
women’s perception of their anxiety level before the procedure. This time lapse could 
possibly have also affected women’s reported overall experience and pain scores. As only 
four insertions did not use local anaesthesia, meaningful comparison of overall IUD insertion 
pain with use and non-use of local anaesthesia was not possible. 
The prevalence of injectable local anaesthesia use here may not be applicable to most 
providers of intrauterine contraception. Furthermore, by the design of this study it cannot be 
ascertained if the pain experienced by patient participants was influenced by the use of local 
anaesthesia, or that a similar pain score distribution would be obtained if local anaesthesia 
was not used for most of the IUD insertions. This study did not take the opportunity to 
examine how characteristics of providers may have affected the anxiety, overall experience 
or pain scores of the patients. This is because the questionnaires for providers were also 
anonymous. 
 
Differences in results in relation to other studies 
 
This study and its findings appear similar to a recently published secondary analysis of pain 
reported in a trial of intracervical lidocaine gel for IUD insertion by Maguire et al.
15
. Their 
providers’ assessment of maximum pain during IUD insertion was found to be significantly 
lower than the maximum reported to have been experienced by the patients (p < 0.001) with a 
moderately positive correlation (Spearman’s rho 0.53, p < 0.001). Their trial also involved 
both copper and levonorgestrel-impregnated intrauterine devices, use of local anaesthesia and 
pain assessment on a numerical rating scale. In another study of 93 nulliparous women over 
10 months, Berger et al. (1976)
16
 found an even greater disparity between the percentage of 
patients (6.5%) who the health professionals identified as having experienced severe pain 
with IUD insertion and those patients (41.2%) who actually reported severe pain. However 
their result may have been biased by: the insertion of larger devices in 55 of the participants 
(Lippes loops A or B were inserted in 27 women, and the Dalkon shield in 28 women); all 
participants having been nulliparous; as well as patients’ reporting of total pain experienced 
with IUD insertion after they had left the clinic while the health professionals on the other 
hand had assessed pain with the IUD insertion procedure only
16
. We avoided this last 
possible bias by asking both patients and providers for overall experience and pain, and to 
complete their questionnaires just after the consultation in the clinic and at the same time. 
Our study findings may be more applicable to routine practice than those of other studies. 
There were no exclusion criteria based on age or recent delivery and most patients were 
either nulligravid or nulliparous. Also, confidential reporting and anonymity of patients was 
ensured by using a self-explanatory numerical rating scale for pain measurement, rather than 
using a visual analogue scale that will have required an assistant. Nulligravidity and 
nulliparity were identified as pain predictors similar to previous large randomized and case 
control studies
17,18
 but pain scores obtained here were higher than in these previous studies 
despite the use of local anaesthesia for the majority of IUD insertions. Cultural background 
may be a factor influencing outcomes. Lower levels of pain have been observed in Chile
17
, 
Denmark
19
 and developing countries
20,21
 in comparison to the United Kingdom
22
 and 
Sweden
23
. 
 
Relevance of findings: Implications for clinicians and policymakers 
 
Despite the finding that severity of pain experienced by women in this study was not related 
to their anxiety, there is evidence to show that the psyche has a role to play
24
. Less anxious 
and better informed patients suffer less pain than their more anxious counterparts
22,25,26
. 
Therapies including analgesia, lavender and ‘verbal anaesthesia’ have been used and 
recommended respectively to reduce anxiety and pain perceived by patients during IUD 
insertion
22,27,28
. 
 
Though pain may be a valid reason for some women not to embrace a very effective method 
of contraception, the provision of intrauterine contraception appears to be acceptable to most 
women when performed according to recommended practice
8,9
 . This involves reducing pain 
by a holistic approach that includes the option of local anaesthesia, as depicted in this study. 
Use of local anaesthesia should be considered by health professionals who perform IUD 
insertions and discussed with women who choose to use intrauterine contraception until more 
efficacious means of pain relief are identified. 
 
Unanswered questions and future research 
 
Further study of how providers can better predict and manage patients’ pain with IUD 
insertion is required, especially for nulligravid and nulliparous women who have been 
identified as likely to experience more pain than their counterparts. Also, there are no 
published studies on the use of 3% Plain Mepivacaine (2.2 ml, Scandonest
®
) as a local 
anaesthetic for IUD insertion and this study was not designed to evaluate its ability to reduce 
pain with the insertion procedure. This product could be further investigated as the search for 
effective analgesia for insertion of intrauterine contraception continues. 
 
CONCLUSION 
 
This study on the pain and/or discomfort experienced by women having the insertion of an 
intrauterine method of contraception, most of whom had local anaesthesia, suggests that most 
women and their health professionals found the procedure acceptable. However, health 
professionals should be aware that women may experience a greater degree of pain during the 
procedure than providers may perceive, a difference which health professionals should 
consider in their management of these women. 
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